Bayer AG (BAYRY)
5.41
+0.05
(+0.93%)
USD |
OTCM |
Nov 14, 15:59
Bayer Total Liabilities (Quarterly): 90.05B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 90.05B |
March 31, 2024 | 90.84B |
December 31, 2023 | 91.95B |
September 30, 2023 | 88.59B |
June 30, 2023 | 91.88B |
March 31, 2023 | 91.64B |
December 31, 2022 | 92.17B |
September 30, 2022 | 88.01B |
June 30, 2022 | 94.63B |
March 31, 2022 | 98.41B |
December 31, 2021 | 98.59B |
September 30, 2021 | 98.91B |
June 30, 2021 | 99.78B |
March 31, 2021 | 98.48B |
December 31, 2020 | 105.94B |
September 30, 2020 | 103.37B |
June 30, 2020 | 98.75B |
March 31, 2020 | 84.59B |
December 31, 2019 | 88.20B |
September 30, 2019 | 92.58B |
June 30, 2019 | 94.87B |
March 31, 2019 | 92.22B |
December 31, 2018 | 92.18B |
September 30, 2018 | 91.84B |
June 30, 2018 | 103.26B |
Date | Value |
---|---|
March 31, 2018 | 45.63B |
December 31, 2017 | 45.86B |
September 30, 2017 | 46.48B |
June 30, 2017 | 53.94B |
March 31, 2017 | 52.57B |
December 31, 2016 | 53.22B |
September 30, 2016 | 58.05B |
June 30, 2016 | 57.22B |
March 31, 2016 | 58.77B |
December 31, 2015 | 52.99B |
September 30, 2015 | 58.39B |
June 30, 2015 | 59.67B |
March 31, 2015 | 59.32B |
December 31, 2014 | 60.82B |
September 30, 2014 | 51.17B |
June 30, 2014 | 48.29B |
March 31, 2014 | 48.64B |
December 31, 2013 | 42.13B |
September 30, 2013 | 42.84B |
June 30, 2013 | 43.88B |
March 31, 2013 | 42.40B |
December 31, 2012 | 43.33B |
September 30, 2012 | 44.08B |
June 30, 2012 | 42.03B |
March 31, 2012 | 45.60B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
84.59B
Minimum
Mar 2020
105.94B
Maximum
Dec 2020
94.46B
Average
92.17B
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
CureVac NV | 193.27M |
Affimed NV | 26.22M |
InflaRx NV | 16.09M |
BioNTech SE | 3.671B |
Immatics NV | 256.27M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 128.48B |
Shareholders Equity (Quarterly) | 38.25B |
Current Ratio | 1.272 |